Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$687,895,182
+$57,612,860 QoQ
Shares Held
2,733,648
-5.7% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#65
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. ABBV ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,333,307 | $1,599,208,548 | |
| 2 | JNJ |
Johnson & Johnson
|
3,780,752 | $960,197,585 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
2,733,648 | $687,895,182 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,809,518 | $489,523,063 | |
| 5 | AMGN |
Amgen Inc
|
904,954 | $327,701,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,051,819 | $259,226,812 | |
| 7 | PFE |
Pfizer Inc
|
8,609,603 | $207,319,240 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,347,347 | $192,874,134 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $687,895,182 | 2,733,648 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $630,282,322 | 2,897,983 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $677,043,517 | 2,963,121 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $703,697,988 | 3,039,207 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $569,831,682 | 3,069,883 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $630,799,768 | 3,010,690 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $539,686,628 | 3,037,066 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $609,477,192 | 3,086,273 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $542,373,854 | 3,162,161 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $592,828,553 | 3,255,511 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $508,738,460 | 3,282,819 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $486,882,131 | 3,266,350 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $436,942,863 | 3,243,100 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $505,146,961 | 3,169,649 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $484,760,346 | 2,999,569 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $386,947,293 | 2,883,148 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $426,530,229 | 2,784,867 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $435,130,798 | 2,684,170 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $361,223,098 | 2,667,822 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $283,715,359 | 2,630,160 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $302,043,484 | 2,681,494 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $306,631,846 | 2,833,412 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $320,784,705 | 2,993,791 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $266,919,576 | 3,047,375 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $296,534,133 | 3,020,311 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $176,710,133 | 2,319,335 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||